Developer docs
API playgroundTry for free, no card

Search company profiles

AnteAGE

Full company profile

uuid000br5j

Namestring
AnteAGE
Legal namestring
Cellese
Websiteurl
anteage.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

AnteAGE, operating as a division of Cellese (a privately held biotech company), is a growth factor and exosome-based skincare company headquartered in Irvine, California. The company develops and commercializes skincare products built on proprietary Cytosignal cell technology, which uses recombinant growth factors and biomimetic exosomes (Biosomes) cultured in laboratory-controlled environments. Its product portfolio spans three tiers: (1) AnteAGE MD, exclusively physician-dispensed products for medical aesthetic practices, dermatologists, and plastic surgeons including Serum, Accelerator, MDX Biosome Solution, Growth Factor Solutions for skin and hair, and Biogel; (2) AnteAGE Professional, topical solutions for estheticians offering microneedling and facial treatments; and (3) AnteAGE Home Care, direct-to-consumer products including Eye Reset, Barrier Repair with Biosomes, and home microneedling systems. Core technical differentiators include hybrid source exosome technology, lyophilized preservation for potency, and 100% cell-free, cruelty-free, paraben-free, and pathogen-free formulations.

The company operates a multi-channel distribution model combining enterprise field sales to authorized medical providers (with required dispensing physician oversight), channel partner distribution through a vetted authorized provider network spanning 35+ countries, and direct-to-consumer e-commerce through anteage.com. Regional entities (AnteAGE Europe and AnteAGE Middle East) support international operations in the UK, Ireland, and UAE. Pricing for premium SKUs ranges from $110 to $324, positioning the brand in the medical-grade skincare segment. Named customers include Cleveland Clinic, Vancouver Laser, Tribeca Medspa, SkinPerfect, and Epicentre.

The business has executed a sustained product launch cadence from 2020 through 2026, including geographic expansion into the UK (2020-2022), women's health aesthetics (Vaginal Rejuvenation Solution, 2022), hair regeneration (Home Hair System, 2022), consumer eye care (Eye Reset, 2023), and the P.E.A.R.L. multi-targeted system combining exosomes and PDRN (2025). The company is privately held with no disclosed external funding rounds, operating within the Cellese parent structure.

Short descriptiontext

AnteAGE, a division of biotech company Cellese, develops and sells growth factor and exosome-based skincare products across physician-dispensed, professional esthetician, and direct-to-consumer channels, serving medical aesthetic practices, dermatologists, and home care consumers globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersIrvine, United States
HQ citystring
Irvine
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
growth factor skincare, exosome aesthetics, professional skincare systems, physician-dispensed skincare, regenerative anti-aging
Industry3 codes
PRIMARYCRABAAAB
Treatment Skincare (Serums, Actives, Acne & Anti-aging)
SECONDARYCRABALAF
Professional Skincare & Facial Treatments
Consumer Products & Retail/Beauty & Personal Care/Professional Salon & Spa Products
SECONDARYHLAKACAE
Cosmetic Dermatology (Aesthetic Injectables)
NAICS code2 codes
  • Toilet Preparation Manufacturing32562
  • Toilet Preparation Manufacturing325620
SIC code2 codes
  • Perfumes, Cosmetics & Other Toilet Preparations2844
  • Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics2840
Product category
Medical Aesthetic Skincare
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Professional Product Sales
TypeOne Time License
Description

Sale of AnteAGE MD treatment solutions and professional skincare products exclusively to physicians, med spas, and licensed aesthetic practitioners. Products include Serum, Accelerator, Growth Factor Solution, Hair Growth Factor Solution, Biogel, and MDX Biosome System.

anteage.com
2Consumer Home Care Sales
TypeOne Time License
Description

Direct-to-consumer sales of home skincare products through anteage.com and authorized provider e-commerce portals. Includes Serum, Accelerator, Eye Reset, Barrier Repair, and at-home treatment solutions.

anteage.com
3Professional Skincare Line
TypeOne Time License
Description

Sale of AnteAGE Professional line products to estheticians and skincare professionals for microneedling and facial treatments.

anteage.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details4 tiers
1AnteAGE MD Biosome System - Professional treatment system
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$324.00 - Includes Serum and Accelerator for in-office use

anteage.com
2AnteAGE Pro System 30mL
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$220.00 - Professional-grade skincare system

anteage.com
3Barrier Repair with Biosomes 50mL
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$130.00 - Consumer home care product

anteage.com
4Eye Reset
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$110.00 - Consumer eye care product

anteage.com
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1P.E.A.R.L.
Description

Complete Multi-Targeted System combining Exosomes and PDRN for in-office aesthetic treatments

anteage.com
+2 more records
Core offering1 text field

AnteAGE manufactures and sells recombinant growth factor and biomimetic exosome (Biosome) skincare products through a multi-tiered channel. Its portfolio includes physician-dispensed AnteAGE MD treatment solutions for in-office aesthetic procedures, AnteAGE Professional systems for estheticians performing microneedling and facials, and AnteAGE Home Care products sold directly to consumers for daily anti-aging skincare and hair regeneration.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Improved skin firmness, reduced redness, decreased signs of aging, improved skin texture and tone
Product overview1 text field

AnteAGE is a growth factor skincare company offering a multi-tiered product portfolio spanning professional in-office treatments, physician-dispensed medical skincare, and consumer home care. The core product lines include: (1) AnteAGE MD System - a two-step Serum and Accelerator daily skincare system with recombinant growth factors; (2) AnteAGE MDX Biosome Solution - a lyophilized biomimetic exosome product for in-office procedures; (3) Professional treatment products including Growth Factor Solutions and Biogel for microneedling, laser, and other aesthetic treatments; (4) Targeted treatments like Eye Reset and Barrier Repair with Biosomes; and (5) Hair regeneration solutions. The company also offers the P.E.A.R.L. system combining Exosomes and PDRN. Products are cruelty-free, cell-free, paraben-free, and pathogen-free, utilizing Cytosignal technology with recombinant growth factors and cytokines derived from stem cell research.

Product and service1 record
1AnteAGE MD Biosome System
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Professional-channel skincare brand with physician-dispensed lines focused on anti-aging and post-procedure care. Comparable on professional-only distribution and treatment-oriented product positioning.

TypeDirect peer
Description

Professional skincare line sold through spas, physicians, and licensed professionals with a focus on treatment-oriented serums. Comparable in professional-channel GTM and clinical positioning for aesthetic practices.

3Alastin Skincare
TypeDirect peer
Description

Galderma-owned physician-dispensed skincare line built around TriHex Technology for procedure support and anti-aging. Closely comparable on channel (authorized providers), regenerative science positioning, and post-procedure use cases.

TypeDirect peer
Description

Physician-dispensed skincare brand with strong presence in dermatology offices and med spas. Comparable in physician-channel distribution and medical-grade skincare positioning, particularly around post-procedure care.

TypeDirect peer
Description

Zein Obagi-founded brand exclusively sold through physicians and medically directed spas. Comparable in physician-dispensed, results-oriented anti-aging positioning and provider-network go-to-market.

6SkinCeuticals
TypeBroad incumbent
Description

L'Oréal-owned professional skincare brand with deep penetration in dermatology and med-spa channels. Comparable in professional skincare positioning, though it operates as part of a much larger portfolio with broader retail and physician reach.

TypeDirect peer
Description

Physician-dispensed skincare brand owned by Allergan/AbbVie, known for growth factor-based products (e.g., TNS) sold through dermatologists and med spas. Directly comparable in channel strategy, professional positioning, and growth factor science.

TypeDirect peer
Description

Physician-dispensed skincare brand originally built on PSP (Processed Skin Cell Proteins) growth factor technology. Direct competitor in growth factor skincare sold through dermatologists and plastic surgeons.

TypeBroad incumbent
Description

Global professional skincare brand sold through skin therapists and licensed estheticians. Comparable in professional-channel distribution and treatment-oriented anti-aging positioning, though it is a broader portfolio player.

10Plated Skin Science
TypeEmerging player
Description

Direct-to-consumer exosome-based skincare brand using platelet-derived growth factor technology. Comparable in exosome/growth factor science, though primarily DTC rather than physician-dispensed.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AnteAGE

Medical Aesthetic Skincareanteage.com

AnteAGE, a division of biotech company Cellese, develops and sells growth factor and exosome-based skincare products across physician-dispensed, professional esthetician, and direct-to-consumer channels, serving medical aesthetic practices, dermatologists, and home care consumers globally.

What AnteAGE does

AnteAGE, operating as a division of Cellese (a privately held biotech company), is a growth factor and exosome-based skincare company headquartered in Irvine, California. The company develops and commercializes skincare products built on proprietary Cytosignal cell technology, which uses recombinant growth factors and biomimetic exosomes (Biosomes) cultured in laboratory-controlled environments. Its product portfolio spans three tiers: (1) AnteAGE MD, exclusively physician-dispensed products for medical aesthetic practices, dermatologists, and plastic surgeons including Serum, Accelerator, MDX Biosome Solution, Growth Factor Solutions for skin and hair, and Biogel; (2) AnteAGE Professional, topical solutions for estheticians offering microneedling and facial treatments; and (3) AnteAGE Home Care, direct-to-consumer products including Eye Reset, Barrier Repair with Biosomes, and home microneedling systems. Core technical differentiators include hybrid source exosome technology, lyophilized preservation for potency, and 100% cell-free, cruelty-free, paraben-free, and pathogen-free formulations.

The company operates a multi-channel distribution model combining enterprise field sales to authorized medical providers (with required dispensing physician oversight), channel partner distribution through a vetted authorized provider network spanning 35+ countries, and direct-to-consumer e-commerce through anteage.com. Regional entities (AnteAGE Europe and AnteAGE Middle East) support international operations in the UK, Ireland, and UAE. Pricing for premium SKUs ranges from $110 to $324, positioning the brand in the medical-grade skincare segment. Named customers include Cleveland Clinic, Vancouver Laser, Tribeca Medspa, SkinPerfect, and Epicentre.

The business has executed a sustained product launch cadence from 2020 through 2026, including geographic expansion into the UK (2020-2022), women's health aesthetics (Vaginal Rejuvenation Solution, 2022), hair regeneration (Home Hair System, 2022), consumer eye care (Eye Reset, 2023), and the P.E.A.R.L. multi-targeted system combining exosomes and PDRN (2025). The company is privately held with no disclosed external funding rounds, operating within the Cellese parent structure.

AnteAGE firmographics

Firmographics
Name
AnteAGE
Legal name
Cellese
Website
https://anteage.com
Company type
Private
Operating status
Operating
Headcount range
11–50 employees
Short description
AnteAGE, a division of biotech company Cellese, develops and sells growth factor and exosome-based skincare products across physician-dispensed, professional esthetician, and direct-to-consumer channels, serving medical aesthetic practices, dermatologists, and home care consumers globally.
Ownership category
akta.pro rank

AnteAGE industry classification

Industry
Product category
Medical Aesthetic Skincare
NAICS
Toilet Preparation Manufacturing (32562), Toilet Preparation Manufacturing (325620)
SIC
Perfumes, Cosmetics & Other Toilet Preparations (2844), Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (2840)
akta.pro industry
PRIMARYCRABAAAB
Treatment Skincare (Serums, Actives, Acne & Anti-aging)
SECONDARYCRABALAF
Professional Skincare & Facial Treatments
Consumer Products & Retail/Beauty & Personal Care/Professional Salon & Spa Products
SECONDARYHLAKACAE
Cosmetic Dermatology (Aesthetic Injectables)

Keywords

  • Growth factor skincare
  • Exosome aesthetics
  • Professional skincare systems
  • Physician-dispensed skincare
  • Regenerative anti-aging

Where AnteAGE is headquartered

Location

Headquarters

HQ city
Irvine
HQ country
United States
HQ region
North America

Offices1 record

Markets served

AnteAGE business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Medical Professional Product Sales: Sale of AnteAGE MD treatment solutions and professional skincare products exclusively to physicians, med spas, and licensed aesthetic practitioners. Products include Serum, Accelerator, Growth Factor Solution, Hair Growth Factor Solution, Biogel, and MDX Biosome System.
  2. Consumer Home Care Sales: Direct-to-consumer sales of home skincare products through anteage.com and authorized provider e-commerce portals. Includes Serum, Accelerator, Eye Reset, Barrier Repair, and at-home treatment solutions.
  3. Professional Skincare Line: Sale of AnteAGE Professional line products to estheticians and skincare professionals for microneedling and facial treatments.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goAnteAGE MD Biosome System - Professional treatment system
One time/ perpetual licensePay-as-you-goAnteAGE Pro System 30mL
One time/ perpetual licensePay-as-you-goBarrier Repair with Biosomes 50mL
One time/ perpetual licensePay-as-you-goEye Reset

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

AnteAGE product offering

Product offering

Core offering

AnteAGE manufactures and sells recombinant growth factor and biomimetic exosome (Biosome) skincare products through a multi-tiered channel. Its portfolio includes physician-dispensed AnteAGE MD treatment solutions for in-office aesthetic procedures, AnteAGE Professional systems for estheticians performing microneedling and facials, and AnteAGE Home Care products sold directly to consumers for daily anti-aging skincare and hair regeneration.

Product overview

AnteAGE is a growth factor skincare company offering a multi-tiered product portfolio spanning professional in-office treatments, physician-dispensed medical skincare, and consumer home care. The core product lines include: (1) AnteAGE MD System - a two-step Serum and Accelerator daily skincare system with recombinant growth factors; (2) AnteAGE MDX Biosome Solution - a lyophilized biomimetic exosome product for in-office procedures; (3) Professional treatment products including Growth Factor Solutions and Biogel for microneedling, laser, and other aesthetic treatments; (4) Targeted treatments like Eye Reset and Barrier Repair with Biosomes; and (5) Hair regeneration solutions. The company also offers the P.E.A.R.L. system combining Exosomes and PDRN. Products are cruelty-free, cell-free, paraben-free, and pathogen-free, utilizing Cytosignal technology with recombinant growth factors and cytokines derived from stem cell research.

Differentiator

Problem solved

Functional benefit

Brands

  • P.E.A.R.L. Complete Multi-Targeted System combining Exosomes and PDRN for in-office aesthetic treatments
  • Biosomes
  • AnteAGE MDX

Products and services

  • AnteAGE MD Biosome System

Quantifiable outcome

  • Improved skin firmness, reduced redness, decreased signs of aging, improved skin texture and tone

Companies that use AnteAGE

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles3 records

AnteAGE technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

AnteAGE partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

AnteAGE competitors and assessment

Company assessment

Direct peers

  • Revision Skincare: Professional-channel skincare brand with physician-dispensed lines focused on anti-aging and post-procedure care. Comparable on professional-only distribution and treatment-oriented product positioning.
  • iS Clinical: Professional skincare line sold through spas, physicians, and licensed professionals with a focus on treatment-oriented serums. Comparable in professional-channel GTM and clinical positioning for aesthetic practices.
  • Alastin Skincare: Galderma-owned physician-dispensed skincare line built around TriHex Technology for procedure support and anti-aging. Closely comparable on channel (authorized providers), regenerative science positioning, and post-procedure use cases.
  • EltaMD: Physician-dispensed skincare brand with strong presence in dermatology offices and med spas. Comparable in physician-channel distribution and medical-grade skincare positioning, particularly around post-procedure care.
  • ZO Skin Health: Zein Obagi-founded brand exclusively sold through physicians and medically directed spas. Comparable in physician-dispensed, results-oriented anti-aging positioning and provider-network go-to-market.
  • SkinMedica: Physician-dispensed skincare brand owned by Allergan/AbbVie, known for growth factor-based products (e.g., TNS) sold through dermatologists and med spas. Directly comparable in channel strategy, professional positioning, and growth factor science.
  • Neocutis: Physician-dispensed skincare brand originally built on PSP (Processed Skin Cell Proteins) growth factor technology. Direct competitor in growth factor skincare sold through dermatologists and plastic surgeons.

Broad incumbents

  • SkinCeuticals: L'Oréal-owned professional skincare brand with deep penetration in dermatology and med-spa channels. Comparable in professional skincare positioning, though it operates as part of a much larger portfolio with broader retail and physician reach.
  • Dermalogica: Global professional skincare brand sold through skin therapists and licensed estheticians. Comparable in professional-channel distribution and treatment-oriented anti-aging positioning, though it is a broader portfolio player.

Emerging players

  • Plated Skin Science: Direct-to-consumer exosome-based skincare brand using platelet-derived growth factor technology. Comparable in exosome/growth factor science, though primarily DTC rather than physician-dispensed.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

AnteAGE social profiles

Digital presence

AnteAGE compliance and trust

Trust signal

Compliance5 records

AnteAGE financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AnteAGE leadership team

Management profile

Number of profiles

Profiles1 record

AnteAGE subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

AnteAGE funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AnteAGE M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AnteAGE

What does AnteAGE do?

AnteAGE manufactures and sells recombinant growth factor and biomimetic exosome (Biosome) skincare products through a multi-tiered channel. Its portfolio includes physician-dispensed AnteAGE MD treatment solutions for in-office aesthetic procedures, AnteAGE Professional systems for estheticians performing microneedling and facials, and AnteAGE Home Care products sold directly to consumers for daily anti-aging skincare and hair regeneration.

Is AnteAGE a public or private company?

AnteAGE is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was AnteAGE founded?

AnteAGE was founded in -1. It employs 11 to 50 people.

Where is AnteAGE based?

AnteAGE is headquartered in Irvine, United States, in the North America region.

How does AnteAGE make money?

Three revenue lines are on record. Medical Professional Product Sales are the primary driver. The others are consumer Home Care Sales and professional Skincare Line.

Who are AnteAGE's main competitors?

Direct peers on record are Revision Skincare, iS Clinical, Alastin Skincare, EltaMD, ZO Skin Health, SkinMedica and Neocutis. Broad incumbents are SkinCeuticals and Dermalogica. Plated Skin Science is listed as an emerging player.

Does AnteAGE have an API?

No public API is recorded for AnteAGE.

What industry is AnteAGE in?

AnteAGE's product category is Medical Aesthetic Skincare. Its primary akta.pro industry code is CRABAAAB, Treatment Skincare (Serums, Actives, Acne & Anti-aging), with a secondary code of CRABALAF, Professional Skincare & Facial Treatments. Its NAICS code is 32562 and its SIC code is 2844.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals